Treatment with an anti-CD4 monoclonal antibody strongly ameliorates established rat adjuvant arthritis

Clinical and Experimental Immunology

Volumn 103, Issue 2, 1996, Pages 273-278

  Pelegri C ^a   Morante, M P ^a   Castellote, C ^a   Franch, A ^a   Castell, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Arthritis; CD4; CD8; Immunotherapy; Monoclonal antibody

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MONOCLONAL ANTIBODY; OKT 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE SUBPOPULATION;

EID: 0030029609     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-624.x     Document Type: Article

References (31)

1. Paulus HE, Machleder HI, Levine S, Yu DTY, MacDonald NS. Lymphocyte involvement in rheumatoid arthritis: studies during thoracic duct drainage. Arthritis Rheum 1977; 20:1249-62.
2. Kotzin BL, Strober S, Engleman EG et al. Treatment of intractable rheumatoid arthritis with total lymphoid irradiation. N Engl J Med 1981; 305:969-76.
3. Duke O, Panayi GS, Janossy G, Poulter LW. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 1982; 49:22-30.
4. Panayi GS. The immunopathogenesis of rheumatoid arthritis. Clin Exp Immunol 1992; 10:305-7.
5. Herzog C, Walker C, Müller W et al. Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I Effect of clinical course and circulating T cells. J Autoimmun 1989; 2:627-42
6. Horneff G, Burmester GR, Emmrich F, Kalden JR. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum 1991; 34:129-40.
7. Goldberg D, Morel P, Chatenoud L et al. Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. J Autoimmun 1991; 4:617-30.
8. Reiter C, Kakavand B, Rieber EP, Schattenkirchner M, Riethmüller G, Krüger K. Treatment of rheumatoid arthritis with monoclonal CD4 antibody M-T151. Arthritis Rheum 1991; 34:525-36.
9. Wendung D, Wijdenes J, Racadot E, Morel-Fourrier B. Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis. J Rheumatol 1991; 18:325-7.
10. Moreland LW, Bucy RP, Tilden A et al. Use of a chimeric monoclonal anti-CD4 antibody in patients with refractory rheumatoid arthritis. Arthritis Rheum 1993; 36:307-18.
11. Van der Lubbe PA, Reiter C, Breedveld FC, Krüger K, Schattenkirchner M, Sanders ME, Riethmüller G. Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis. Arthritis Rheum 1993; 36:1375-9.
12. Choy EHS, Chikanza IC, Kingsley GH, Corrigall V, Panayi GS. Treatment of rheumatoid arthritis with single dose or weekly pulses of chimaeric anti-CD4 monoclonal antibody. Scand J Immunol 1992; 36:291-8.
13. Moreland L, Pratt P, Mayes M et al. Minimal efficacy of a depleting chimeric anti-CD4 (cM-T412) in treatment of patients with refractory rheumatoid arthritis receiving concomitant methotrexate (abstract). Arthritis Rheum 1993; 36 (Suppl. 9):S39.
14. Van der Lubbe PA, Dijkmans BAC, Markusse HM, Nässander U, Breedveld FC. A randomized, double-blind, placebo-controlled study of CD4 monoclonal antibody therapy in early rheumatoid arthritis. Arthritis Rheum 1995; 38:1097-106.
15. Ranges GE, Sriram S, Cooper SM. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 1985; 162:1105-10.
16. Hom JT, Butler LD, Riedl PE, Bendele AM. The progression of the inflammation in established collagen-induced arthritis can be altered by treatments with immunological or pharmacological agents with inhibit T cell activities. Eur J Immunol 1988; 18:881-8.
17. Williams RO, Mason LJ, Feldmann M, Maini RN. Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. Proc Natl Acad Sci USA 1994; 91:2762-6.
18. Billingham MEJ, Hicks CA, Carney SL. Monoclonal antibodies and arthritis. Agents Actions 1990; 29:77-87.
19. Pelegri C, Morante MP, Castellote C, Castell M, Franch A. Administration of a non-depleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge. Parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25. Cell Immunol 1995; 165:177-82.
20. Wood FD, Pearson CM, Tanaka A. Capacity of mycobacterial Wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy 1969; 35:456-7.
21. White RAH, Mason DW, Williams AF, Galfre G, Milstein C. T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody. J Exp Med 1978; 148:664-73.
22. Brideau RJ, Carter PB, McMaster WR, Mason DW, Williams AF. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol 1980; 10:609-15.
23. + lymphocytes in female Wistar rats. Ann Hematol 1993; 67:115-8.
24. Franch A, Cassany S, Castellote C, Castell M. Adjuvant arthritis pretreatment with type II collagen and Mycobacterium butyricum. Immunobiol 1992; 186:351-61.
25. Taurog JD, Sandberg GP, Mahowald ML. The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer. Cell Immunol 1983; 80:198-204.
26. Holoshitz J, Naparstek Y, Ben-Nun A, Cohen IR. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science 1983; 219:56-58.
27. Holoshitz J, Matitiau A, Cohen IR. Arthritis induced in rats by cloned T lymphocytes responsive to mycobacteria but not to collagen type II. J Clin Invest 1984; 73:211-5.
28. Van den Brock MF, Van de Langerijt LGM, Van Bruggen MCJ, Billingham MEJ, Van den Berg WB. Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis. Eur J Immunol 1992; 22:57-61.
29. Goldschmidt TJ, Holmdahl R. Therapeutic effects of monoclonal antibodies to αβTCR but not to CD4 on collagen-induced arthritis in the rat. Cell Immunol 1994; 154:240-8.
30. Mannie MD, Morrison-Plummer J, McConnell TJ. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody. J Immunol 1993; 151:7293-306.
31. Larsson P, Holmdahl R, Dencker L, Klareskog L. In vivo treatment with W3/13 (anti-pan T) but not with OX8 (anti-suppressor/cytotoxic T) monoclonal antibodies impedes the development of adjuvant arthritis in rats. Immunology 1985; 56:383-91.